The second edition of this well-received book provides a clear and practical guidance on all aspects of the angioplasty treatment with drug coated balloons. It will cover all areas concerning the typical candidate patient for a DCB-angioplasty, including complex coronary, high-risk bleeding and CHIP patients. This type of patients is becoming more and more common and requires specific attention and investment from the healthcare systems to be properly managed. The book will be divided into 4 macro-areas (tecnhical insights; clinical applications in coronary artery disease; clinical applications in peripheral arterial disease; advantages and applications in specific settings), each of which include specific chapters on the latest technical and scientific advances, offering a thorough literature coverage as well. Additional sections are devoted to understanding the mechanisms of stent failure and future diagnostic and therapeutic areas, depending on the disease and the patient's risk profile. The Authors of this book have been selected from among the world's most experienced, from Europe, North and South America and Asia. This book will become a must-read for all Interventional cardiologists, radiologists and vascular surgeons dealing with angioplasty, because a deep understanding of the DCB technology will help them improving the clinical outcome of their patients. 

Bernardo Cortese, MD, MSc, FESC, FSCAI is Professor of Medicine at UH-Case Western Reserve University in Cleveland, President of Fondazione Ricerca e Innovazione Cardiovascolare (Milano, Italy) and Chairman of DCB Academy (USA). His career has focused on advancing care for patients with coronary artery disease through translational research, complex interventional techniques, and large-scale international collaborations. He has served as principal investigator, steering committee member, or country coordinator in more than 70 clinical trials, including pivotal randomized studies involving drug-coated balloons (DCB), stents, bioresorbable scaffolds, antithrombotics, and peripheral percutaneous interventions.

He is a CHIP and CTO operator and focused his clinical and technical approach to complex and assisted PCI to protect the frail and sick patients.

He has extensive experience mentoring clinical and research Fellows, leading academic initiatives, and coordinating centers and investigators across institutional boundaries. These qualifications clearly define a successful integration of cardiology practice with biomedical research.

DCB Academy is an international Institution devoted to the education of cardiologists, by organinzing symposia at major cardiovascular meetings, lessons and publications. The current number of Fellows from 15 countries is: 23.

Fondazione RIC  is a leading Institution devoted to cardiovascular research and clinical trials planning and conduction, with >8000 patients enrolled in clinical trials by 2026.